UF pharmacy dean named president-elect of national pharmacology society

Julie A. Johnson, Pharm.D., dean and distinguished professor of the University of Florida College of Pharmacy, is the new president-elect of the American Society for Clinical Pharmacology and Therapeutics. Johnson will assume the leadership role March 5 at the society’s 116th annual meeting in New Orleans, where she also will serve as a featured speaker.

The first of two featured speakers at the annual meeting, Johnson will share an overview of her current research efforts through her presentation, Pharmacogenomics: Discovery through Clinical Implementation.

Based in Alexandria, Virginia, the American Society for Clinical Pharmacology and Therapeutics has more than 2,100 members who work to advance the science and therapeutic practice of human pharmacology for the benefit of patients and society.

During her tenure as president-elect, Johnson — a nationally recognized researcher in pharmacogenomics — will become a member of the society’s executive committee and an ex officio member of other board-designated committees.

“Dr. Johnson has been a member of ASCPT since 1993 and has a strong scientific background that well-positions her to help advance the strategic priorities of the society,” said Sharon Swan, chief executive officer for ASCPT. As a member, Johnson has published several papers in Clinical Pharmacology & Therapeutics, and currently serves as an editorial board member for the journal. She also is an active member of the Scientific Program Committee.

Johnson is a member of the Institute of Medicine, a fellow of the American College of Clinical Pharmacy, an honorary fellow of the American College of Clinical Pharmacology, and a fellow of the American Heart Association Functional Genomics and Translational Biology Council.